Hilar Cholangiocarcinoma: A Review and Commentary
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 7 (1) , 55-66
- https://doi.org/10.1007/s10434-000-0055-4
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinomaCancer, 1998
- Intraluminal brachytherapy in the treatment of bile duct carcinomasAustralasian Radiology, 1997
- Factors Influencing Postoperative Morbidity, Mortality, and Survival After Resection for Hilar CholangiocarcinomaAnnals of Surgery, 1996
- Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapyBritish Journal of Surgery, 1995
- An Argument Against Routine Percutaneous Biopsy, ERCP, or Biliary Stent Placement in Patients with Clinically Resectable Periampullary MassesPancreas, 1995
- Improvements in Survival by Aggressive Resections of Hilar CholangiocarcinomaAnnals of Surgery, 1993
- The Interrelation Between Sclerosing Cholangitis and Ulcerative Colitis in Patients Undergoing Liver TransplantationAnnals of Surgery, 1992
- Management Strategies in Resection for Hilar CholangiocarcinomaAnnals of Surgery, 1992
- Cytologic brushings of ductal lesions during ERCPGastrointestinal Endoscopy, 1991
- Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: a Southwest Oncology Group StudyEuropean Journal of Cancer and Clinical Oncology, 1983